Apr 02, 2019
Motegrity(TM) (prucalopride), the Only Serotonin-4 Receptor Agonist for Adults with Chronic Idiopathic Constipation (CIC), is Now Available in the United States
Mar 21, 2019
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)
Feb 28, 2019
Sierra Oncology Reports 2018 Year End Results
Dec 03, 2018
Updated Data from Phase 1/2 Open-Label Study of BCMA-Directed CAR-T Cell Therapy LCAR-B38M Show Tolerable Safety Profile, High Overall Response and MRD Negative Rate in Treatment of Patients with Advanced Relapsed or Refractory Multiple Myeloma
Jun 07, 2018
Myovant Provides Corporate Update and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2018
May 05, 2018
Takeda Activities at American Psychiatric Association (APA) Annual Meeting Innovation Zone Highlight Advancements in Mental Health
Mar 23, 2018
TiGenix and Takeda Announce Alofisel® (darvadstrocel) Receives Approval to Treat Complex Perianal Fistulas in Crohn's Disease in Europe
Jan 05, 2018
Takeda Announces Intention to Acquire TiGenix
Nov 17, 2017
The Boston Globe Names Takeda Pharmaceuticals U.S.A., Inc. a Top Place to Work for 2017
Nov 10, 2017
The Chicago Tribune Names Takeda Pharmaceuticals U.S.A., Inc. A Workplace Achiever of the Chicago Area 2017 Top Workplaces Award
Nov 06, 2017
Takeda, Lundbeck and Advocate Health Care Research Study Aims to Enhance Patient-Provider Engagement in Major Depressive Disorder Treatment using Digital Technology
Nov 01, 2017
The global hematologic malignancies market is estimated to reach USD 85.8 billion by 2025
Oct 06, 2017
Takeda Donates $100,000 to Local, Regional Charities as Part of Company's Takeda Cares Day Event
Oct 04, 2017
Takeda Welcomes The Honorable Susana Mendoza As Guest Speaker At Deerfield Headquarters To Celebrate Company's Commitment to Latino Culture
Sep 26, 2017
Takeda Named To 2017 Working Mother "100 Best Companies" For Leadership In Family Benefits And Paid Leave
Aug 17, 2017
Hikma Announces Expanded Licensing Agreement with Takeda for New Products in the Middle East and North Africa
Jul 25, 2017
Takeda and BioSurfaces Announce Joint Research Program to Explore Promising Devices to Treat Gastrointestinal Diseases